Dr Sebastian Weller
Dr Sebastian Weller is Partner at ADVANT Beiten's Dusseldorf office and member of the Corporate/M&A practice group. He focuses on Corporate/M&A as well as Private Equity/Venture Capital, supporting clients in Germany and abroad particularly with corporate transactions (including restructuring projects, joint ventures or financing rounds). Among his clients are large corporate and medium-sized companies, private equity/venture capital funds and start-ups, as well as institutional and strategic investors. One industry focus is on the healthcare industry where he advises longstanding national and international clients.
Dr Weller studied law at Justus-Liebig-University, Gießen, and achieved his doctorate at the University of Augsburg. Since 2019, he has been working as Partner with ADVANT Beiten. Before joining ADVANT Beiten he worked for national and international law firms in Dusseldorf.
Dr Sebastian Weller is recommended.
(The Legal 500 Germany 2024)
"He is outstanding in many respects. Professionally, he's one of the best I've ever had the pleasure of meeting, and he's also extremely good at communicating. He always knew when we should ask for more external expertise and what the best course of action was. Truly unique in terms of cooperation.";
"Simply incredibly skilled both professionally and as a project manager. He had everything under control at all times and you always felt well informed. Really exceptional to work with. So the project proceeded extremely smoothly as well!"
(The Legal 500 Germany 2023 & The Legal 500 EMEA 2023)
- VGR Scientific Association for business and corporate law
- digihub e.V.
- Private Equity Forum NRW e.V.
- Wirtschaftsclub Duesseldorf
Publications / Lectures
Healthcare & Life Sciences: Quo vadis Buy-and-Build?, in: M&A Review, 14 December 2023
Comments to the Judgement of Regional Court Munich I, 10 Dec. 2013 - 5HK O 1387/10: Establishing an effective Compliance System is part of the entire liability of the Board of Directors, in: Compliance-Berater 2014, p. 176
Benefit Clauses in Termination Agreements with Members of the Board of Directors - Stones or Bread?, in: GWR 2014, p. 167 -172
Conference Report: "4. Augsburger Forum für Medizinprodukterecht" – Conference Report, in: MPR 2008, p. 164 f.
Reprocessing of Used Medical Products - Uncertainties and Problems in Practice - in: MPR 2012, p. 82 et seq.
Reprocessing of Medical Devices – Is there legal certainty in Germany? Is the USA a shining example?, in: Journal of Medical Device Regulation – JMDR November 2011, p. 30 et seq.
Lecture on "Investing in START-UPs - The Legal View" for the Manager Lounge on 1 October at the Business Club in Dusseldorf ;
Regular lectures on "Venture Capital" issues at Heinrich-Heine-University, Dusseldorf.
ADVANT Beiten Advises Laumann Group Especially on Antitrust Law Issues in Connection with the Acquisition of a Majority Share in Ponzio Polska
Seven New Equity Partners: Strong Growth From Own Ranks
ADVANT Beiten advises Medline on the acquisition of Asid Bonz
ADVANT Beiten Advises MYPOSTER on Takeover and Exit of JUNIQE
BEITEN BURKHARDT Advises on Acquisition of Vinylit Fassaden GmbH
BEITEN BURKHARDT Advises Suzhou TZTEK Technology Co Ltd on the Acquisition of MueTec Automatisierte Mikroskopie und Meßtechnik GmbH
BEITEN BURKHARDT elects a total of eleven Partners from six different Competence
BEITEN BURKHARDT Advises Quadpack Industries on Acquisition of Louvrette GmbH
BEITEN BURKHARDT Advises Hotelplan Group on Takeover of vtours
BEITEN BURKHARDT Advises B. Braun on Takeover of Nephtec